Alto Neuroscience has reported positive outcomes from the interim analysis of its double-blind Phase IIb trial of oral ALTO-300, as an adjunctive treatment for major depressive disorder (MDD). The ...

Christmas was approaching so Rick Hollering, executive director of the Youth Services Alliance, brought a gift to his class at The Academy. Hollering had been visiting The Academy, a school within the ...

Valneva has announced positive outcomes from its Phase III VLA1553-321 trial of the single-shot IXCHIQ chikungunya virus (CHIKV) vaccine in adolescents. The trial demonstrated a ‘sustained ...